Open Access UCL Research: Diagnostic test accuracy and cost‐effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma - UCL Discovery https://t.co/uduXtcGQCO
'Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma' Latest review from our member Dr Sarah Jefferies & UK collaborators led by @MedicalBristol https://t.co/JezQ4AFVXO
¿Cuál es la exactitud de las pruebas diagnósticas y coste‐efectividad de las pruebas de codeleción de los brazos cromosómicos 1p y 19q en personas con glioma? Lee la nueva revisión aquí https://t.co/x1B0GHCPgh https://t.co/fQvZAjXE8w
PODCAST - @Cochrane_GNOCG author talks about the latest evidence on tests that might help in planning the treatment of patients with a glioma ➡️https://t.co/qkUjCo9XYA #braintumour #glioma #braincancer #oligodendroglioma
Our Cochrane review looking at the diagnostic test accuracy of tests for 1p19q codeletion in glioma has been published.
New paper published in @CochraneLibrary by @A_McAleenan and other ICEP members investigating the diagnostic test accuracy and cost‐effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma https://t.co/7L1TMzNiP7
What is the most accurate and cost‐effective way to identify 1p/19q codeletion in glioma?. https://t.co/yDzggJGlpc New @Cochrane_GNOCG systematic review looks at diagnose a #glioma known as an #oligodendroglioma. #braintumor #braincancer